CYLEMBIO
Live / Registered — Registered (as of 04 Feb 2025)
What this means for you
Registered since 04 Feb 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 04 Feb 2031: the §8 declaration of use).
Record
- Serial number
- 98394978
- Registration number
- 7676178
- Mark type
- Design + words
- Filed
- 06 Feb 2024
- Published for opposition
- 17 Dec 2024
- Registered
- 04 Feb 2025
- Next maintenance filing
- §8 declaration of use, due by 04 Feb 2031 (grace period to 04 Aug 2031)
- Attorney of record
- Bryce J. Maynard
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; synthetic peptides for pharmaceutical use for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; vaccines
Owner
- IO Biotech ApS, Copenhagen N, DK
- IO Biotech ApS, Copenhagen N, DK
- IO Biotech ApS, Copenhagen N, DK
Board proceedings on this mark
The owner also pleads this mark in 1 other Board proceeding.
Prosecution history
- 04 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 17 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Dec 2024 — PUBLISHED FOR OPPOSITION
- 11 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Oct 2024 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 07 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Oct 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 11 Sept 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Sept 2024 — NON-FINAL ACTION E-MAILED
- 11 Sept 2024 — NON-FINAL ACTION WRITTEN
- 29 Aug 2024 — ASSIGNED TO EXAMINER
- 15 Mar 2024 — NOTICE OF DESIGN SEARCH CODE E-MAILED